- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03938350
Dialectical Behavior Therapy for Pregnant Women
Dialectical Behavior Therapy Skills Training for High-Risk African American Pregnant Women: Feasibility and Acceptability of Implementation in Prenatal Clinics
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The cumulative effects of adverse childhood experiences (ACEs), including trauma exposure, parent mental health problems, family dysfunction, and experiences of racism can lead to prolonged activation of stress response systems, known as toxic stress. Toxic stress can adversely influence maternal and childhood health. Increased numbers of ACEs are associated with negative birth outcomes such as decreased birth weight and gestational age at delivery. An intergenerational transmission of toxic stress has been evidenced in disruptions to children's hypothalamic pituitary adrenal (HPA)-axis functioning that result in life long health impacts. African American women are at increased risk for ACEs and similarly experience disparities in birth outcomes including low-birth weight and preterm birth. Many low-income, urban African American women are navigating the demands of pregnancy while confronting compounding chronic stressors, such as dangerous neighborhoods, lack of adequate and accessible public services, poverty, and the historical context of injustice, discrimination, and disadvantage. Although early life adversity can have serious consequences lasting across the lifespan and generations, interventions during critical periods such as pregnancy have the potential to prevent the intergenerational transmission of toxic stress and associated health disparities.
Prenatal mindfulness-based interventions have been shown to reduce depression, anxiety, and stress in pregnant women. Mindfulness is recommended as a culturally relevant intervention to reduce stress-related health disparities among African American and has been found to be feasible and acceptable to African American women. Further, mindfulness-based interventions are efficacious for a variety of mental health conditions and are cost-effective and scalable in diverse settings. Dialectical Behavior Therapy (DBT) Skills Training is a group format mindfulness-based intervention with demonstrated efficacy for increasing emotional regulation abilities and reducing depression and PTSD symptoms. DBT Skills Training has been adapted for trauma-exposed populations and is considered a transdiagnostic intervention for emotion dysregulation. Further, it is increasing being used with parents who have trauma histories and/or mental health problems. Adapting DBT skills for pregnant women with a history of ACEs and current depression and/or PTSD symptoms is novel and has the potential to interrupt the intergenerational cycle of toxic stress by improving maternal stress response, depression, and PTSD, thus reducing the risk of the intergenerational transmission of toxic stress.
This study will examine initial feasibility, acceptability, and effectiveness of an adapted 8-week DBT Skills Training group for mothers-to-be (DBTMTB) for low-income, African American pregnant women with a history of ACEs and current depression and PTSD symptoms to be delivered virtually. This adapted DBT Skills Training to the context of pregnancy will include specific pregnancy and parenting applications of DBT mindfulness and emotion regulation skills and opportunities to practice applying mindfulness and emotion regulation skills to enhance management of chronic stressors. The researchers posit that DBTMTB addresses important contributors to persistent birth outcome health disparities experienced by African American women and has the potential to reduce the cycle of toxic stress and transgenerational transference of disparities in health by improving pregnant women's mental health and stress response.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Georgia
-
Atlanta, Georgia, United States, 30303
- Grady Health System
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Self-identify as African American/Black (includes African American/Black and another race)
- Able to read, speak, and understand English
- Adverse Childhood Experiences (ACE) score ≥ 4 from the Expanded ACE Questionnaire
- PHQ-9 score ≥ 9 or PC-PTSD-5 ≥ 3
- Within first or second trimester at time of recruitment
- Willing and able to participate in research assessments
- Willing and able to participate in a 8-week DBT Skills Training group for mothers-to-be (DBTMTB) Group
- Willing and able to provide informed consent
Exclusion Criteria:
- Presence of intellectual disability or actively displaying psychotic symptoms
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Dialectical Behavior Therapy (DBT) Skills Training
Participants in this group will receive 8 weeks of Dialectical Behavior Therapy (DBT) Skills Training.
|
Standard DBT skills training is a comprehensive intervention for emotion dysregulation that includes four skills modules: (1) mindfulness skills; (2) emotion regulation skills; (3) interpersonal effectiveness skills; and (4) distress tolerance skills designed to target adaptive skills deficits that define emotion dysregulation.
The sessions will be delivered virtually via a HIPAA-compliant video platform.
|
|
No Intervention: Treatment as Usual
Participants in this study arm will receive treatment as usual consisting of routine prenatal care with any mental health assessment, social work involvement or mental health service provision based on clinician referral or self-referral.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recruitment Rate
Time Frame: Baseline
|
Feasibility of the intervention will be assessed by the number of women who agree to participate in the study, among those who are approached about participation.
|
Baseline
|
|
Retention Rate
Time Frame: Week 8
|
Feasibility of the intervention will be assessed by the number of participants completing the 8 week intervention.
|
Week 8
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability of the Intervention
Time Frame: Week 8
|
Acceptability of the intervention will be assessed through qualitative participant feedback.
We will use a 25-item semi-structured interview to explore participants': (1) attitudes and beliefs related to the content of the intervention; (2) experiences with intervention components (e.g., facilitators' teaching skill, group interactions, and intervention exercises like role play/practices); and (3) barriers and facilitators for implementing the skills learned in the intervention in their daily life.
Responses are in text form rather than on a pre-set scale.
|
Week 8
|
|
Change in Patient Health Questionnaire (PHQ-9) Score
Time Frame: Baseline, Week 8
|
The PHQ-9 is a 9-item self-report questionnaire developed to identify patients at risk for depression.
Participants report how often they have been bothered by specific symptoms of depression on a scale of 0 (not at all) to 3 (nearly every day).
Higher scores indicate greater symptoms of depression.
A score of ≥ 9 indicates clinically significant symptoms.
|
Baseline, Week 8
|
|
Change in PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 (PCL-5) Score
Time Frame: Baseline, Week 8
|
The PCL-5 instrument is a 20-item self-report measure that assesses DSM-5 symptoms of PTSD.
Participants report how often they have been bothered by specific symptoms of PTSD on a scale of 0 (not at all) to 4 (extremely).
The total symptom severity score ranges from 0 to 80.
A provisional PTSD diagnosis can be made and a PCL-5 cut-point score of 33 is recommended.
|
Baseline, Week 8
|
|
Change in Difficulties in Emotion Regulation Scale (DERS) Score
Time Frame: Baseline, Week 8
|
The DERS is a 36-item self-report measure that assesses 6 facets of emotion dysregulation.
Participants report how much of the time they feel specific ways on a scale of 1 (almost never) to 5 (almost always).
Totals scores range from 36 to 180 and higher scores indicate greater difficulties with emotion regulation.
|
Baseline, Week 8
|
|
Change in The Reflective Functioning Questionnaire (RFQ-8) Score
Time Frame: Baseline, Week 8
|
The RFQ-8 is an 8-item self-report screener that assesses mentalizing or reflective functioning (understanding intentional mental states such as feelings, desires, and attitudes).
Responses are given on a 7-point scale where 1 = strongly disagree and 7 = strongly agree (scoring is reversed for one item).
Total raw scores range from 8 to 56 where higher scores indicate poorer reflective functioning.
|
Baseline, Week 8
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Briana Woods-Jaeger, PhD, Emory University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00111022
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.